India could bear biggest impact from chikungunya, new maps suggest
Peer-Reviewed Publication
This month, we’re focusing on infectious diseases, a topic that affects lives and communities around the world. Here, you’ll find the latest research news, insights, and discoveries shaping how infectious diseases are being studied, prevented, and treated globally.
Updates every hour. Last Updated: 16-Dec-2025 12:11 ET (16-Dec-2025 17:11 GMT/UTC)
AI model (machine learning) helps researchers create most comprehensive maps of chikungunya infections to date
Data suggests more regions at risk of chikungunya transmission than previously thought
For India, between 5 and 12 million people could be at risk of chikungunya infections each year
Data to help public health professionals already working hard to manage outbreaks
Pediatric data show that the increase in long COVID risk was also accompanied by the increased chance of developing a number of other related conditions
Flu season is fast approaching in the northern hemisphere. And a taste-based influenza test could someday have you swapping nasal swabs for chewing gum. A new molecular sensor has been designed to release a thyme flavor when it encounters the influenza virus. Researchers reporting in ACS Central Science say that they plan to incorporate this type of low-tech sensor into gum or lozenges to increase at-home screenings and potentially prevent pre-symptomatic transmission of the disease.
The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) today announced a co-funded gift of S$2 million from the Novo Nordisk Foundation and Temasek Foundation to support a programme to enhance the diagnostics for severe bacterial infections and combat antimicrobial resistance (AMR), a deadly health issue in Asia.
Children and adolescents were twice as likely to experience long COVID after catching COVID for the second time, compared to their peers with a single previous infection, according to a large study funded by the National Institutes of Health (NIH) and published in Lancet Infectious Diseases. These results run counter to the popular perceptions that COVID in children is "mild" and that reinfections with COVID do not carry the same risk of long COVID that initial infections do.